Effects of protein conformation in docking: improved pose prediction through protein pocket adaptation.

Department of Bioengineering and Therapeutic Sciences, University of California, San Francisco, CA 94158-9001, USA.
Journal of Computer-Aided Molecular Design (Impact Factor: 3.17). 05/2009; 23(6):355-74. DOI: 10.1007/s10822-009-9266-3
Source: PubMed

ABSTRACT Computational methods for docking ligands have been shown to be remarkably dependent on precise protein conformation, where acceptable results in pose prediction have been generally possible only in the artificial case of re-docking a ligand into a protein binding site whose conformation was determined in the presence of the same ligand (the "cognate" docking problem). In such cases, on well curated protein/ligand complexes, accurate dockings can be returned as top-scoring over 75% of the time using tools such as Surflex-Dock. A critical application of docking in modeling for lead optimization requires accurate pose prediction for novel ligands, ranging from simple synthetic analogs to very different molecular scaffolds. Typical results for widely used programs in the "cross-docking case" (making use of a single fixed protein conformation) have rates closer to 20% success. By making use of protein conformations from multiple complexes, Surflex-Dock yields an average success rate of 61% across eight pharmaceutically relevant targets. Following docking, protein pocket adaptation and rescoring identifies single pose families that are correct an average of 67% of the time. Consideration of the best of two pose families (from alternate scoring regimes) yields a 75% mean success rate.

  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: We have previously validated a probabilistic framework that combined computational approaches for predicting the biological activities of small molecule drugs. Molecule comparison methods included molecular structural similarity metrics and similarity computed from lexical analysis of text in drug package inserts. Here we present an analysis of novel drug/target predictions, focusing on those that were not obvious based on known pharmacological crosstalk. Considering those cases where the predicted target was an enzyme with known 3D structure allowed incorporation of information from molecular docking and protein binding pocket similarity in addition to ligand-based comparisons. Taken together, the combination of orthogonal information sources led to investigation of a surprising predicted relationship between a transcription factor and an enzyme, specifically, PPARα and the cyclooxygenase enzymes. These predictions were confirmed by direct biochemical experiments which validate the approach and show for the first time that PPARα agonists are cyclooxygenase inhibitors.
    Journal of Computer-Aided Molecular Design 11/2014; 29(2). DOI:10.1007/s10822-014-9815-2 · 3.17 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: The use of predictive computational methods in the drug discovery process is in a state of continual growth. Over the last two decades, an increasingly large number of docking tools have been developed to identify hits or optimize lead molecules through in-silico screening of chemical libraries to proteins. In recent years, focus has been on implementing protein flexibility and water molecules. Our efforts led to the development of FITTED first reported in 2007 and further developed since then. In this study, we wished to evaluate the impact of protein flexibility and occurrence of water molecules on the accuracy of the FITTED docking program to discriminate active compounds from inactive compounds in virtual screening (VS) campaigns. For this purpose, a total of 171 proteins co-crystallized with small molecules representing 40 unique enzymes and receptors as well as sets of known ligands and decoys were selected from the PDB and the Directory of Useful Decoys (DUD) respectively. This study revealed that implementing displaceable crystallographic or computationally placed particle water molecules and protein flexibility can improve the enrichment in active compounds. In addition, an informed decision based on library diversity or research objectives (hit discovery vs. lead optimization) on which implementation to use may lead to significant improvements.
    Journal of Chemical Information and Modeling 10/2014; DOI:10.1021/ci500299h · 4.30 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: Abstract Chapter 2 focuses, in detail, on the many considerations encountered in lead discovery and lead modification stages of modern rational drug design, as typically practiced in pharmaceutical companies and many academic research laboratories. Examples emphasize how the concepts of organic chemistry are applied during the practice of these key stages of drug discovery. Major topics of discussion are the various sources for lead compounds, including virtual screening, computational methods, and fragment-based approaches, and desired properties of lead compounds. This is followed by an exploration of the objectives, considerations, and methods for subsequently optimizing lead compounds across multiple parameters such as potency, selectivity, and ADME properties. Approaches for the identification of the pharmacophore and for the determination of structure-activity relationships, including quantitative and other computational and molecular graphics-based methods, are discussed, and properties important to oral bioavailability and membrane permeability are described.
    The Organic Chemistry of Drug Design and Drug Action (Third Edition), Third Edit edited by Holladay, Richard B SilvermanMark W, 01/2014: pages 19-122; Academic Press., ISBN: 9780123820303


Available from